Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Increasing Rate of Fatal Streptococcus pyogenes Bacteriemia-A Challenge for Prompt Diagnosis and Appropriate Therapy in Real Praxis

V. Adamkova, VG. Adamkova, G. Kroneislova, J. Zavora, M. Kroneislova, M. Huptych, H. Lahoda Brodska

. 2024 ; 12 (5) : . [pub] 20240515

Status not-indexed Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24012767

Grant support
MH CZ - DRO - VFN00064165 Ministry of Health

Streptococcus pyogenes, group A streptococci (GAS) bacteriaemia, is a life-threatening infection with high mortality, requiring fast diagnosis together with the use of appropriate antibiotic therapy as soon as possible. Our study analysed data from 93 patients with GAS bacteraemia at the General University Hospital in Prague between January 2006 and March 2024. In the years 2016-2019 there was an increase in GAS bacteraemia. Mortality in the period 2006-2019 was 21.9%; in the period 2020-2024, the mortality increased to 41.4%, p = 0.08. At the same time, in the post-2020 period, the time from hospital admission to death was reduced from 9.5 days to 3 days. A significant predictor of worse outcome in this period was high levels of procalcitonin, >35.1 μg/L (100% sensitivity and 82.35% specificity), and lactate, >5 mmol/L (90.91% sensitivity and 91.67% specificity). Myoglobin was a significant predictor in both compared periods, the AUC was 0.771, p = 0.044, and the AUC was an even 0.889, p ≤ 0.001, respectively. All isolates of S. pyogenes were susceptible to penicillin, and resistance to clindamycin was 20.3% from 2006-2019 and 10.3% in 2020-2024. Appropriate therapy was initiated in 89.1%. and 96.6%, respectively. We hypothesise that the increase in mortality after 2020 might be due to a decrease in the immune status of the population.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24012767
003      
CZ-PrNML
005      
20240726151353.0
007      
ta
008      
240723s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/microorganisms12050995 $2 doi
035    __
$a (PubMed)38792824
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Adamkova, Vaclava $u Clinical Microbiology and ATB Centre, General University Hospital, 128 08 Prague, Czech Republic $1 https://orcid.org/0000000276295365 $7 xx0070151
245    10
$a Increasing Rate of Fatal Streptococcus pyogenes Bacteriemia-A Challenge for Prompt Diagnosis and Appropriate Therapy in Real Praxis / $c V. Adamkova, VG. Adamkova, G. Kroneislova, J. Zavora, M. Kroneislova, M. Huptych, H. Lahoda Brodska
520    9_
$a Streptococcus pyogenes, group A streptococci (GAS) bacteriaemia, is a life-threatening infection with high mortality, requiring fast diagnosis together with the use of appropriate antibiotic therapy as soon as possible. Our study analysed data from 93 patients with GAS bacteraemia at the General University Hospital in Prague between January 2006 and March 2024. In the years 2016-2019 there was an increase in GAS bacteraemia. Mortality in the period 2006-2019 was 21.9%; in the period 2020-2024, the mortality increased to 41.4%, p = 0.08. At the same time, in the post-2020 period, the time from hospital admission to death was reduced from 9.5 days to 3 days. A significant predictor of worse outcome in this period was high levels of procalcitonin, >35.1 μg/L (100% sensitivity and 82.35% specificity), and lactate, >5 mmol/L (90.91% sensitivity and 91.67% specificity). Myoglobin was a significant predictor in both compared periods, the AUC was 0.771, p = 0.044, and the AUC was an even 0.889, p ≤ 0.001, respectively. All isolates of S. pyogenes were susceptible to penicillin, and resistance to clindamycin was 20.3% from 2006-2019 and 10.3% in 2020-2024. Appropriate therapy was initiated in 89.1%. and 96.6%, respectively. We hypothesise that the increase in mortality after 2020 might be due to a decrease in the immune status of the population.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Adamkova, Vanda Gabriela $u Department of Plant Sciences, University of Cambridge, Cambridge CB2 3EA, UK $1 https://orcid.org/0000000226519527
700    1_
$a Kroneislova, Gabriela $u Clinical Microbiology and ATB Centre, General University Hospital, 128 08 Prague, Czech Republic $1 https://orcid.org/0009000536075498
700    1_
$a Zavora, Jan $u Clinical Microbiology and ATB Centre, General University Hospital, 128 08 Prague, Czech Republic $u Department of Medical Microbiology, Palacky University, 779 00 Olomouc, Czech Republic
700    1_
$a Kroneislova, Marie $u Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, 9712 CP Groningen, The Netherlands $u Department of Surgery, University Hospital Bulovka, 180 00 Prague, Czech Republic
700    1_
$a Huptych, Michal $u Czech Institute of Informatics, Robotics and Cybernetics (CIIRC), Czech Technical University in Prague, 160 00 Prague, Czech Republic
700    1_
$a Lahoda Brodska, Helena $u Clinical Biochemistry, General University Hospital, 128 08 Prague, Czech Republic $1 https://orcid.org/0000000179628287 $7 jn20000400273
773    0_
$w MED00198767 $t Microorganisms $x 2076-2607 $g Roč. 12, č. 5 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38792824 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20240726151345 $b ABA008
999    __
$a ok $b bmc $g 2125473 $s 1224630
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 12 $c 5 $e 20240515 $i 2076-2607 $m Microorganisms $n Microorganisms $x MED00198767
GRA    __
$a MH CZ - DRO - VFN00064165 $p Ministry of Health
LZP    __
$a Pubmed-20240723

Find record

Citation metrics

Archiving options